Literature DB >> 17443026

Basal and postprandial gut peptides affecting food intake in lean and obese pregnant women.

K Sodowski1, K Zwirska-Korczala, D Kuka, M Kukla, P Budziszewska, B Czuba, A Włoch, W Cnota, W Bielański, T Brzozowski, J F Rehfeld, R Zdun, P C Konturek.   

Abstract

Maternal obesity has been reported as a risk factor for various maternal and fetal complications. The aim of the present study was to examine the patterns of basal and postprandial plasma concentrations of certain gut hormones affecting food intake such as acylated ghrelin, peptide YY(3-36) (PYY(3-36)), cholecystokinin (CCK), insulin and glucose in pregnant women with varying body mass gain during physiological pregnancy. The study included 34 women with singleton pregnancies in the 2(nd) trimester of gestation. The examined pregnant women were divided into 4 groups; I. control pregnancy (CP) with weight gain below 0.5 kg/week; II. overweight low weight gain <1 kg/week (OLWG), III. overweight high weight gain >1 kg/week (OHWG); morbidly obese pregnant with weight gain >1.5 kg/week (MOP). The basal acylated-ghrelin levels in MOP subjects were significantly higher than those in CP and no usual suppression of acylated ghrelin after the meal observed in CP as well as in OLWG and OHWG was found in MOP women. Basal PYY(3-36) plasma levels were similar in CP, OLWG and OHWG but in MOP was significantly reduced and no significant increase in hormone level, typically observed in CP, was detected after a meal in overweight or obese women studied. The fasting CCK and C-reactive protein (CRP) levels in MOP subjects were significantly higher than those in CP and other overweight women. In conclusion, we found that pregnant women with overweight and obesity exhibit significant changes in fasting and postprandial gut hormones affecting food intake such as acylated ghrelin, PYY(3-36) and CCK as well as in CRP and these changes might contribute, at least in part, the development of obesity in pregnancy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17443026

Source DB:  PubMed          Journal:  J Physiol Pharmacol        ISSN: 0867-5910            Impact factor:   3.011


  5 in total

1.  Ghrelin and peptide YY in postpartum lactating and nonlactating women.

Authors:  D Enette Larson-Meyer; Eric Ravussin; Leonie Heilbronn; Lilian DeJonge
Journal:  Am J Clin Nutr       Date:  2009-12-09       Impact factor: 7.045

2.  The role of peptide YY in appetite regulation and obesity.

Authors:  Efthimia Karra; Keval Chandarana; Rachel L Batterham
Journal:  J Physiol       Date:  2008-12-08       Impact factor: 5.182

3.  Developing Potential Candidates of Preclinical Preeclampsia.

Authors:  Sandra Founds; Xuemei Zeng; David Lykins; James M Roberts
Journal:  Int J Mol Sci       Date:  2015-11-13       Impact factor: 5.923

4.  Maternal high-fat diet-induced programing of gut taste receptor and inflammatory gene expression in rat offspring is ameliorated by CLA supplementation.

Authors:  Clare M Reynolds; Stephanie A Segovia; Xiaoyuan D Zhang; Clint Gray; Mark H Vickers
Journal:  Physiol Rep       Date:  2015-10

Review 5.  Novel Molecules Regulating Energy Homeostasis: Physiology and Regulation by Macronutrient Intake and Weight Loss.

Authors:  Anna Gavrieli; Christos S Mantzoros
Journal:  Endocrinol Metab (Seoul)       Date:  2016-07-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.